Immatics N.V.2025财年第三财季实现净利润-59.06百万美元，同比减少527.63%

市场透视2025-11-23

11月23日，Immatics N.V.（IMTX.US）公布财报，公告显示公司2025财年第三财季净利润为-59.06百万美元，同比减少527.63%；其中营业收入为6.06百万美元，同比减少89.09%，每股基本收益为-0.49美元。从资产负债表来看，Immatics N.V.（IMTX.US）总负债1.20亿美元，其中短期债务3.38百万美元，资产负债比为5.08，流动比率为0.08。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2585489844?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-23 00:02","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2585489844","market":"us","top_or_hot":-1,"title":"Immatics N.V.2025财年第三财季实现净利润-59.06百万美元，同比减少527.63%","media":"市场透视","content":"<div>\n<p>11月23日，Immatics N.V.（IMTX.US）公布财报，公告显示公司2025财年第三财季净利润为-59.06百万美元，同比减少527.63%；其中营业收入为6.06百万美元，同比减少89.09%，每股基本收益为-0.49美元。从资产负债表来看，Immatics N.V.（IMTX.US）总负债1.20亿美元，其中短期债务3.38百万美元，资产负债比为5.08，流动比率为0.08。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251123000222a70b0755&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Immatics N.V.2025财年第三财季实现净利润-59.06百万美元，同比减少527.63%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nImmatics N.V.2025财年第三财季实现净利润-59.06百万美元，同比减少527.63%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-23 00:02 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251123000222a70b0755&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>11月23日，Immatics N.V.（IMTX.US）公布财报，公告显示公司2025财年第三财季净利润为-59.06百万美元，同比减少527.63%；其中营业收入为6.06百万美元，同比减少89.09%，每股基本收益为-0.49美元。从资产负债表来看，Immatics N.V.（IMTX.US）总负债1.20亿美元，其中短期债务3.38百万美元，资产负债比为5.08，流动比率为0.08。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251123000222a70b0755&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IMTX","symbol_name":"Immatics N.V.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251123000222a70b0755&s=b","article_id":"2585489844","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251123000222a70b0755&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2585489844","pubTimestamp":1763827328,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"11月23日，Immatics N.V.公布财报，公告显示公司2025财年第三财季净利润为-59.06百万美元，同比减少527.63%；其中营业收入为6.06百万美元，同比减少89.09%，每股基本收益为-0.49美元。从资产负债表来看，Immatics N.V.总负债1.20亿美元，其中短期债务3.38百万美元，资产负债比为5.08，流动比率为0.08。该公司通过与第三方制药和生物技术公司签订战略合作协议获得收入。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"IMTX":"Immatics N.V."},"translate_title":"Immatics N.V. achieved net profit of-US $59.06 million in the third fiscal quarter of fiscal year 2025, a year-on-year decrease of 527.63%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IMTX":1.5},"content_text":"11月23日，Immatics N.V.（IMTX.US）公布财报，公告显示公司2025财年第三财季净利润为-59.06百万美元，同比减少527.63%；其中营业收入为6.06百万美元，同比减少89.09%，每股基本收益为-0.49美元。从资产负债表来看，Immatics N.V.（IMTX.US）总负债1.20亿美元，其中短期债务3.38百万美元，资产负债比为5.08，流动比率为0.08。机构评级：截至2025年11月23日，当前有10家机构对Immatics N.V.目标价做出预测，其中目标均价为18.09美元，其中最低目标价为10.92美元，最高目标价为24.87美元。公司简介：Immatics NV 是一家生物技术公司，致力于研发用于治疗癌症患者的T细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司签订战略合作协议获得收入。该公司的最大收入来自美国。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2585489844","isCrawlerRequest":true}